NasdaqCM - Nasdaq Real Time Price USD
HCW Biologics Inc. (HCWB)
9.61
-0.44
(-4.38%)
As of 12:39:01 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BYAM REBECCA Chief Financial Officer | Stock Award(Grant) | Feb 20, 2024 | 1,381,910 |
| FLOWERS LEE Officer | Stock Award(Grant) | Feb 20, 2024 | 190,238 |
| GARRETT SCOTT T Director | Stock Award(Grant) | Feb 20, 2024 | -- |
| GILES LISA M Director | Stock Award(Grant) | Feb 20, 2024 | 35,815 |
| GREENE RICK SCOTT Director | Stock Award(Grant) | Feb 20, 2024 | 44,125 |
| RHODE PETER Officer | Conversion of Exercise of derivative security | Dec 11, 2023 | 77,500 |
| WINER GARY M Director | Purchase | Sep 14, 2023 | 17,000 |
| WONG HING C Chief Executive Officer | Stock Award(Grant) | Feb 20, 2024 | 16,054,200 |
Related Tickers
CNSP CNS Pharmaceuticals, Inc.
1.1803
-13.21%
XLO Xilio Therapeutics, Inc.
0.9501
-17.38%
CTMX CytomX Therapeutics, Inc.
2.1550
-13.80%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
TOVX Theriva Biologics, Inc.
0.5879
+4.98%
KTTA Pasithea Therapeutics Corp.
0.9455
+9.93%
PLRZ Polyrizon Ltd.
0.0131
-54.04%
ZVSA ZyVersa Therapeutics, Inc.
0.5014
-3.20%
CRVS Corvus Pharmaceuticals, Inc.
3.6200
-6.94%
ALZN Alzamend Neuro, Inc.
3.9492
-5.52%